Register Login
Register to leave comments
  • News bot June 9, 2026, 9:20 p.m.

    📋 AXSOME THERAPEUTICS, INC. (AXSM) - Regulatory Update

    Filing Date: 2026-06-09

    Accepted: 2026-06-09 17:19:56

    Event Type: Regulatory Update

    Event Details:

    AXSOME THERAPEUTICS, INC. (AXSM) Announces Regulatory Update AXSOME THERAPEUTICS, INC. (AXSM) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (AXSOME THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    AXS-14 (esreboxetine) Other Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    Placebo Other Phase PHASE2 Multiple Sclerosis ClinicalTrials.gov
    Solriamfetol Other Phase PHASE2 Multiple Sclerosis ClinicalTrials.gov
    AXS-12 (reboxetine) Other Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Monitoring Other Phase PHASE4 Insomnia ClinicalTrials.gov
    Cognitive Behavioral Therapy for Insomnia (CBT-I) Drug Phase PHASE4 Insomnia ClinicalTrials.gov
    Solriamfetol 75 MG Other Phase PHASE4 Insomnia ClinicalTrials.gov
    AXS-07 Other Phase PHASE3 Migraine ClinicalTrials.gov
    AXS-02 (oral zoledronate) Other Phase PHASE3 Complex Regional Pain Syndrome ClinicalTrials.gov
    AXS-02 Other Phase PHASE3 Osteoarthritis, Knee ClinicalTrials.gov
    Bupropion Other Phase PHASE3 Treatment Resistant Major Depressive Disorder ClinicalTrials.gov
    AXS-05 Other Phase PHASE3 Treatment Resistant Major Depressive Disorder ClinicalTrials.gov
    Bupropion SR Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    AXS-05 (dextromethorphan and bupropion) oral tablets Other Phase PHASE3 Major Depressive Disorder ClinicalTrials.gov
    Solriamfetol 150 mg Oral Tablet Other Phase PHASE1 Narcolepsy ClinicalTrials.gov
    Rizatriptan Other Phase PHASE3 Migraine ClinicalTrials.gov
    Meloxicam Other Phase PHASE3 Migraine ClinicalTrials.gov
    AXS-07 (MoSEIC meloxicam and rizatriptan) Other Phase PHASE3 Migraine ClinicalTrials.gov
    No treatment Drug Preclinical Narcolepsy ClinicalTrials.gov
    Other prescription wake-promoting medications or stimulants Drug Preclinical Narcolepsy ClinicalTrials.gov
    Sunosi (solriamfetol) Other Preclinical Narcolepsy ClinicalTrials.gov
    Solriamfetol Oral Tablet Other Phase PHASE4 Excessive Sleepiness ClinicalTrials.gov
    Solriamfetol 300 mg Other Phase PHASE3 Binge-Eating Disorder ClinicalTrials.gov
    Solriamfetol 150 mg Other Phase PHASE3 Binge-Eating Disorder ClinicalTrials.gov
    Solriamfetol 75mg, 150 mg, or 300 mg Other Phase PHASE3 Binge-Eating Disorder ClinicalTrials.gov
    AXS-07 (meloxicam-rizatriptan) Other Phase PHASE3 Migraine ClinicalTrials.gov
    AXS-05 (dextromethorphan-bupropion) Other Phase PHASE3 Agitation in Patients With Dementia of the Alzheimer's Type ClinicalTrials.gov
    Dextromethorphan-Bupropion Other Phase PHASE2 Major Depressive Disorder (MDD) ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AXSOME THERAPEUTICS, INC.
    • Ticker Symbol: AXSM

Search

News categories